Xenon Pharmaceuticals Inc (XENE)
41.20
+1.40
(+3.53%)
USD |
NASDAQ |
Nov 22, 16:00
41.99
+0.78
(+1.91%)
After-Hours: 20:00
Xenon Pharmaceuticals Shares Outstanding: 76.24M for Nov. 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 08, 2024 | 76.24M |
November 06, 2024 | 76.24M |
September 30, 2024 | 75.79M |
August 05, 2024 | 75.76M |
June 30, 2024 | 75.67M |
May 06, 2024 | 75.47M |
April 05, 2024 | 75.46M |
March 31, 2024 | 75.46M |
February 26, 2024 | 75.43M |
December 31, 2023 | 75.37M |
December 04, 2023 | 75.28M |
November 03, 2023 | 65.43M |
September 30, 2023 | 65.00M |
August 04, 2023 | 64.15M |
June 30, 2023 | 63.72M |
May 05, 2023 | 63.56M |
April 04, 2023 | 63.12M |
March 31, 2023 | 63.11M |
February 24, 2023 | 63.04M |
December 31, 2022 | 62.59M |
November 04, 2022 | 62.54M |
September 30, 2022 | 62.54M |
August 05, 2022 | 62.26M |
June 30, 2022 | 62.24M |
June 27, 2022 | 62.20M |
Date | Value |
---|---|
May 06, 2022 | 53.11M |
April 05, 2022 | 53.07M |
March 31, 2022 | 53.06M |
March 16, 2022 | 52.94M |
February 25, 2022 | 51.92M |
January 31, 2022 | 51.90M |
January 11, 2022 | 51.65M |
December 31, 2021 | 51.63M |
November 08, 2021 | 51.59M |
October 08, 2021 | 51.40M |
September 30, 2021 | 41.41M |
August 09, 2021 | 41.12M |
June 30, 2021 | 41.12M |
May 07, 2021 | 40.97M |
April 08, 2021 | 40.96M |
March 31, 2021 | 40.96M |
March 12, 2021 | 40.94M |
February 26, 2021 | 35.81M |
December 31, 2020 | 35.01M |
November 03, 2020 | 35.01M |
September 30, 2020 | 34.99M |
August 04, 2020 | 34.99M |
June 30, 2020 | 34.99M |
May 18, 2020 | 34.97M |
April 06, 2020 | 34.96M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
25.88M
Minimum
Dec 02 2019
76.24M
Maximum
Nov 06 2024
52.74M
Average
52.43M
Median
Shares Outstanding Benchmarks
Aurinia Pharmaceuticals Inc | 143.18M |
Edesa Biotech Inc | 3.247M |
Lexaria Bioscience Corp | 15.81M |
ESSA Pharma Inc | 44.37M |
ImmunoPrecise Antibodies Ltd | 27.92M |